L-Carnitine (Carnitine, Base)

Can help increase the body's metabolism. It is commonly used as a dietary supplement in conjunction with exercise. To help you lose more weight

L-carnitine Base type, special purity > 99% It is a naturally occurring amino acid.

style="border: 1px solid #ddd; border-collapse: collapse; border-collapse:collapse;" Benefit Typical study dose* Key human findings High-quality sources 1 Exercise performance & recovery 2–3 g/day for ≥ 4 weeks (chronic); 3 g single dose (acute) • 2025 double-blind crossover trial in CrossFit® athletes: + 7 % reps vs. placebo after one 3 g dose.
• 2024 systematic review/meta-analysis (12 RCTs, n=402): chronic use ↓ post-exercise blood-lactate (SMD –0.69 mmol/L) and ↑ VO₂ max by 2.2 mL/kg/min.
• 2025 meta-analysis shows lower creatine-kinase & DOMS 24 h after training. ISRCTN Registry, ResearchGate 2 Glucose control & metabolic markers in type 2 diabetes / pre-diabetes 1–4 g/day for 8–52 weeks 2024 dose-response meta-analysis of 36 RCTs (n=3 214) found clinically meaningful reductions in fasting glucose (–9 mg/dL), HbA1c (–0.32 %) and HOMA-IR (–0.43).
2023 ODS umbrella review corroborates ↓ insulin resistance across 41 RCTs. PubMed, Office of Dietary Supplements 3 Cardiovascular support (post-MI, CHF, surgery) 2–6 g/day loading → 2–3 g/day maintenance 2024 literature review reports improved LVEF and reduced arrhythmias; systematic evidence shows post-MI mortality reduction (RR 0.66) without added benefit > 3 g/day. PMC, MDPI 4 Male fertility (idiopathic infertility, asthenozoospermia) 2 g/day for 3–4 months 2025 meta-analysis of 19 RCTs: ↑ total sperm motility (+ 8 %), concentration (+ 6 M/mL) and morphology; 2023 narrative review affirms benefits at 2 g/day, especially combined with acetyl-L-carnitine. PubMed, PMC 5 Cognitive & mood support (acetylated metabolites) 1–2 g/day ALCAR equivalents 2025 Mendelian-randomization study links low acetyl-L-carnitine to poorer global cognition; 2023 review notes slowed cognitive decline and mood improvement in AD & depression trials. PMC, Frontiers 6 Renal anemia & muscle symptoms in hemodialysis 1–2 g IV post-dialysis or 1.5–3 g/day oral 2021 meta-analysis (18 trials) shows ↑ hemoglobin (+ 0.88 g/dL) and ↓ ESA dose (– 1 660 IU/week); 2023 review confirms benefits on anemia and muscle cramps. PubMed, MDPI 7 Weight & body-composition management (adjunct) 1–4 g/day for 8–30 weeks 2025 umbrella meta-analysis (8 MAs, > 16 000 participants) reports modest but significant ↓ body-weight (– 1.1 kg) and waist circumference (– 1.5 cm). PubMed, Office of Dietary Supplements 8 Lipid profile (dyslipidemia, NAFLD) ≥ 2 g/day for ≥ 12 weeks 2023 umbrella meta-analysis indicates ↓ LDL-C (– 8 mg/dL) and ↑ HDL-C (+ 3 mg/dL) when doses exceed 2 g/day. Frontiers

*Doses reflect studies in L-carnitine base or its free form; L-tartrate and acetyl-L-carnitine are metabolized to the same molecule but have different pharmacokinetics.

---

Mechanistic highlights

1. Mitochondrial fatty-acid shuttle: transports long-chain acyl-CoA into mitochondria, supporting β-oxidation and ATP production, especially during exercise.
2. Acetyl buffering: maintains CoA/acetyl-CoA balance, influencing glucose–fat “fuel sparing.”
3. Anti-oxidant & anti-inflammatory actions: down-regulation of CRP, TNF-α and lipid peroxidation noted in several meta-analyses.
4. Sperm motility: provides acetyl-CoA for epididymal sperm maturation and scavenges ROS in seminal plasma.
5. Neurotransmitter modulation: acetyl-L-carnitine donates acetyl groups for acetylcholine synthesis and epigenetic regulation of BDNF and mGlu2 expression.
   
   

---

Safety & practical use

• Usual supplemental range: 500 mg–3 g/day split doses with meals.
• Upper-dose tolerance: GI distress and fishy body-odor start ~ 3 g/day; seizures reported in predisposed individuals.
• Drug interactions: may potentiate warfarin; monitor INR.
• TMAO concern: gut bacteria can convert excess carnitine to trimethylamine-N-oxide—an emerging CVD risk marker, though causality remains debated.
• Populations needing medical oversight: chronic kidney disease, seizure disorders, pregnancy/lactation.

Mechanism	-
Appearance	-
Longevity	-
Strength	-
Storage	-
Shelf Life	-
Allergen(s)	-
Dosage (Range)	-
Recommended Dosage	-
Dosage (Per Day)	-
Recommended Dosage (Per Day)	-
Mix Method	-
Heat Resistance	-
Stable in pH range	-
Solubility	-
Product Types	-
INCI	-